A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 92.68
GOOG 691.85
MSFT 49.81
FB 116.11
BAC 14.56

Recently Added

SGY 0.97
WLL 11.42
RMRK 0.00
SYF 30.45
MYCC 13.06

Gaining Speed

SYF 30.45
RMRK 0.00
WLL 11.42
MYCC 13.06
SGY 0.97

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!